In the News

/In the News

Self-Driving Cars On The Horizon

Self-driving cars, being tested in California and Nevada, are making driving a possibility for people with low vision and other limitations. Read article. You can read more about this technology in the upcoming Spring 2012 issue of SupportSightNEWS. In this issue, internationally reknowned physician and researcher, Dr. Philip Rosenfeld, discusses this technology and how it [...]

March 30th, 2012|

Interesting Article On Eylea, New Wet AMD Drug By Regeneron

Read full article from the Reuters.

March 14th, 2012|

Dame Judi Dench Announces AMD Diagnosis

Click here to see full report.

February 18th, 2012|

Counterfeit Avastin Confirmed In U.S.

BREAKING NEWS: Important information just received from Genentech confirming the presence of counterfeit Avastin in the United States. If you are being treated with Avastin, please speak with your retinal specialist/physician to see if this could affect you. We're told the FDA will be releasing a statement shortly. For more information, please click here to [...]

February 14th, 2012|

Gene Therapy Research From Penn Vet & Scheie Eye Inst. Cures Retinitis Pigmentosa In Dogs

Members of a University of Pennsylvania research team have shown that they can prevent, or even reverse, a blinding retinal disease, X-linked Retinitis Pigmentosa, or XLRP, in dogs. The disease in humans and dogs is caused by defects in the RPGR gene and results in early, severe and progressive vision loss. It is one of the most common inherited forms of retinal degeneration in man. “Every single abnormal feature that defines the disease in the dogs was corrected following treatment,” said lead author William Beltran, assistant professor of ophthalmology at Penn’s School of Veterinary Medicine. […]

January 24th, 2012|

Implantable Ocular Device Milestone Reached

Genentech Announces First Milestone Payment to Device-Maker ForSight VISION4, Inc. in Development of Sustained Delivery Lucentis South San Francisco, Calif. – January 13, 2012 – Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced it will make its first milestone payment to ForSight VISION4, Inc. as part of an exclusive license agreement to develop the company’s investigational drug delivery device, designed to provide sustained delivery of Lucentis® (ranibizumab). […]

January 13th, 2012|

Palm Beach Daily News Article

Macula Vision Research Foundation puts focus on research – If there’s one statement that’s bound to attract Palm Beach donors, it’s the label that’s attached to every piece of literature distributed by Macula Vision Research Foundation. “One hundred percent of every dollar donated goes directly to research.” That’s impressive, and that’s because this foundation, dedicated to finding cures for blindness caused by retinal diseases such as macular degeneration, has all its administrative costs totally funded by a family foundation. […]

January 4th, 2012|

Art4Vision Opens New Gallery In Ft. Lauderdale To Benefit MVRF

The gala event, held December 3rd at The Museum of Art Fort Lauderdale, showcased the work of Art Wolfe with all proceeds benefiting Macula Vision Research Foundation.  Special thanks to Dr. Scott Anagnoste and Art4Vision for supporting MVRF's Research programs.

December 21st, 2011|

Curing Blindness

Curing blindness! Macula Vision Research Foundation (MVRF) is proud to share the results of a clinical trial that has restored sight to its participants. One research study at a time, MVRF is curing blindness! This study, solely funded by MVRF, demonstrates the effectiveness of gene therapy in treating Leber’s Congenital Amaurosis (LCA), a form of [...]

July 12th, 2011|

Join Us In Cleveland!

MVRF is hosting a SupportSight Seminar in Cleveland on Saturday, July 23rd, 2011. We hope you can join us! When: 9:00 a.m. – 12:00 p.m. Where: Corporate College East […]

June 27th, 2011|